Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, cilt.37, sa.3, ss.280-286, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 37 Sayı: 3
- Basım Tarihi: 2015
- Doi Numarası: 10.3109/08923973.2015.1027918
- Dergi Adı: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.280-286
- Hacettepe Üniversitesi Adresli: Hayır
Özet
Context: Although subcutaneous allergen immunotherapy (SCIT) is effective in allergic rhinitis (AR) and asthma, it carries a risk of local and systemic adverse reactions.